The Norwegian Directorate of Health has
apologised for the way in which ME patients in Norway have been treated.
This follows the publication of the ground-breaking research from Haukeland
University in Bergen (click here).

After the publication of
the Rituximab study by Fluge et al (2011) and extensive media coverage
since then the Norwegian Directorate of Health gave a short statement on
TV2 channel, see TV2 Nettavisen (click
here).

A statement from
the Norwegian Directorate of Health has been received where they
apologise for not having provided the necessary and proper health
services to persons with ME.

Such a public apology from
a governmental health agency has never occurred before.

Bjørn Guldvog,
Deputy Director General of theNorwegian Directorate of Health
made the following statement